The WEAR study is long-term interventional study designed to evaluate patient and clinician use of the Alio platform, per its FDA cleared indications.
End Stage Kidney Disease
The WEAR study is long-term interventional study designed to evaluate patient and clinician use of the Alio platform, per its FDA cleared indications.
Alio WEAR Study: Long-term Wear of the Alio Platform
-
Site 1, Huntley, Illinois, United States, 60142
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Alio, Inc.,
David Whittaker, MD, STUDY_DIRECTOR, Alio
2024-04-01